news roundup
RAPS plans to spend more than 2 million euros over the next three years by launching new events and resources to serve the needs of regulatory professionals in the region.
| advertisment
Transform clinical trials with better data collection
Build a trial around patients, not technology. Learn how a modern EDC helps deliver complex studies and improve data collection in this white paper.
 Read now. |
WIRB-Copernicus Group announces the acquisition of ThreeWire, a global patient recruitment, enrollment and retention firm that assists biopharma, medical device companies and CROs achieve trial enrollment and retention goals.
| advertisment
Planning Gene Therapy Research? Prepare for institutional biosafety committee (IBC) Review with these tips from the Biosafety Officer at a leading IRB.
 Learn more |
Adventist Health System and Bio-Optronics announce the implementation and rollout of the Clinical Conductor Clinical Trial Management System (CTMS) at two of the health care system's research institutes.
| advertisment
Winning the RAT race: A new Center of Excellence to drive development of regenerative medicines
On Demand
 Learn more |
The Commonwealth Vigilance Workbench (CVW) Longitudinal assists drug researchers and regulators explore and refine safety signals using evidence from healthcare data sources.
|
|
|
advertisment
|
|
| advertisment
Talking the Patients' Language – the importance of effective, patient-centered engagement
Live Webinar: Tuesday, June 6 at 8:00am EDT
 Register now |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Blog Posts
Continuum Clinical recently partnered with Lyft to deliver the convenience of transportation directly into the hands of patients. Nariman Nasser, VP of Site Optimization at Continuum Clinical, elaborates on the partnership in this interview.
In a world given over dangerously to social-media sensationalism, systematic distrust of science, and blind acceptance of fake news, vaccine deniers are gaining ground.
Oncology
George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Vector Oncology's Pharma Services Division, to provide oncology services in that region.
Orphan drugs will account for more than 21% of worldwide brand-name prescription drug sales in 2022, up from 6% in 2000, according to an analysis by EvaluatePharma.
Drug developers are using surrogate endpoints to monitor the effectiveness of immunotherapies, taking into account the differences between immunotherapy and traditional treatments.
|
|
|
Articles
This article provides a descriptive analysis of what we have learned from EMA data releases over the first three months in terms of approaches to anonymization, how the EMA anonymization guidelines are being implemented by manufacturers, and how patient privacy is balanced against data utility.
| advertisment
Is Your CTMS Working for You? Unify and Optimize Your Approach to Clinical Trials
On Demand
 Learn more |
The FDA tries to strike the balance, and/or accomplish the goods of society and the individual patient through its evolving expanded access program. This program, under certain conditions and criteria, gives patients access to investigational products not approved for marketing. But there is ongoing dialogue about achieving the right balance for this access.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
